1. Home
  2. PCSA vs WKSP Comparison

PCSA vs WKSP Comparison

Compare PCSA & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$0.27

Market Cap

14.7M

Sector

Health Care

ML Signal

HOLD

Logo Worksport Ltd.

WKSP

Worksport Ltd.

HOLD

Current Price

$2.90

Market Cap

17.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCSA
WKSP
Founded
2011
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
14.7M
17.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PCSA
WKSP
Price
$0.27
$2.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$1.00
$12.83
AVG Volume (30 Days)
1.1M
241.9K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,286,679.00
Revenue This Year
N/A
$142.95
Revenue Next Year
N/A
$109.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
123.37
52 Week Low
$0.15
$1.92
52 Week High
$1.50
$12.00

Technical Indicators

Market Signals
Indicator
PCSA
WKSP
Relative Strength Index (RSI) 48.05 56.34
Support Level $0.27 $2.47
Resistance Level $0.30 $3.13
Average True Range (ATR) 0.02 0.23
MACD 0.00 0.09
Stochastic Oscillator 62.34 80.51

Price Performance

Historical Comparison
PCSA
WKSP

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The three NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS3117, also referred to as NGC-Gemcitabine (NGC-Gem), and PCS11T, also referred to as NGC-Irinotecan (NGC-Iri).

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

Share on Social Networks: